Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Revisiting Host-Pathogen Interactions in Cystic Fibrosis Lungs in the Era of CFTR Modulators

International Journal of Molecular Sciences(2023)10.3390/ijms24055010Source: DataRank Database

Revisiting Host-Pathogen Interactions in Cystic Fibrosis Lungs in the Era of CFTR Modulators is a research paper published in International Journal of Molecular Sciences (2023). On theSindex it has a DataRank of 0. It has been cited 31 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access31 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 5.18)OA: goldTopics (38)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Matthew G. Higgs ORCID,Marianne S. Muhlebach ORCID,Matthew C. Wolfgang ORCID,Monica Borgatti ORCID,Ilaria Lampronti ORCID

Live enrichment

PubMed:36902441 PMC:PMC10003689 OpenAlex:https://openalex.org/W4323318459

National Institutes of Health

Grant: 1 R01 HL155261

National Institutes of Health

Grant: RIBEIR20P0

National Institutes of Health

Grant: WOLFGA19G0

National Institutes of Health

Grant: MUHLEB17A0

National Institutes of Health

Grant: MUHLEB 22A0

National Institutes of Health

Grant: FFC 10/2022

National Institutes of Health

Grant: FFC 7/2019

NHLBI NIH HHS

Grant: R01 HL155261

National Institutes of Health

Grant: 5R01HL155261-02

Pre-Clinical Evaluation of IRE1beta as a Novel Therapeutic Target for Cystic Fibrosis Airway Mucus Production

FWCI

5.18

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.3390/ijms24055010

publisherhttps://doi.org/10.3390/ijms24055010

publisherhttps://www.mdpi.com/1422-0067/24/5/5010/pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36902441

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10003689

Fields of Study

Cystic Fibrosis Research AdvancesNeonatal Respiratory Health ResearchPneumonia and Respiratory Infections0303 health sciences03 medical and health sciences

MeSH Terms

AdultCystic FibrosisHumansLungPseudomonas aeruginosaStaphylococcal InfectionsCystic Fibrosis Transmembrane Conductance RegulatorHost-Pathogen Interactions

Keywords

Cystic fibrosisCystic fibrosis transmembrane conductance regulatorPseudomonas aeruginosaLungImmunologyInflammationImmune systemBiologyPathogenStaphylococcus aureusMedicineMicrobiologyBacteriaInternal medicineGeneticsAirway epitheliaAirway inflammationAirway InfectionCftr Modulatorsairway epithelia; airway infection; airway inflammation; CFTR modulators; cystic fibrosis; Pseudomonas aeruginosa; Staphylococcus aureusAdultHost-Pathogen InteractionsHumansReviewStaphylococcal Infections

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Revisiting Host-Pathogen Interactions in Cystic Fibrosis Lungs in the Era of CFTR Modulators

FAIR Checklist

Authors (7)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)